Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Nov;163(5):1422-6.e1-4.
doi: 10.1016/j.jpeds.2013.06.021. Epub 2013 Jul 26.

Tetanus, diphtheria, acellular pertussis vaccine during pregnancy: pregnancy and infant health outcomes

Julie H Shakib  1 , Kent Korgenski, Xiaoming Sheng, Michael W Varner, Andrew T Pavia, Carrie L Byington
Affiliations

Tetanus, diphtheria, acellular pertussis vaccine during pregnancy: pregnancy and infant health outcomes

Julie H Shakib et al. J Pediatr. 2013 Nov.

Abstract

Objective: To assess pregnancy and birth outcomes in infants born to women who did or did not receive tetanus, diphtheria, acellular pertussis (Tdap) vaccine during pregnancy.

Study design: Retrospective cohort. Pregnant women 12-45 years of age who received Tdap at Intermountain Healthcare facilities and their infants were identified and compared with mother-infant pairs without documented Tdap from May 2005 through August 2009. Primary measures included pregnancy outcomes and infant health outcomes at birth through 12 months.

Results: From 162,448 pregnancies we identified 138 women (0.08%) with documented Tdap administration during pregnancy (cases); 552 pregnant women without documented Tdap were randomly selected as controls. Of 138 immunized women, 63% received Tdap in the first trimester and 37% after. Tdap was given most commonly as wound prophylaxis. The incidence of spontaneous or elective abortion was no greater in Tdap cases than in controls. There were no significant differences in preterm delivery, gestational age, or birth weight between groups. One or more congenital anomaly was identified in 3.7% (95% CI 1.2%-8.5%) of case infants and 4.4% (95% CI 2.7%-6.5%) of control infants (P = .749). In infants born to women receiving Tdap during pregnancy, 3.6% (0.8%-10.2%) had International Classification of Diseases, Ninth Revision, Clinical Modification diagnoses consistent with complex chronic conditions within 12 months compared with 10.4% (95% CI 7.2%-14.4%) of infants of controls (P = .054).

Conclusions: Documented Tdap administration during pregnancy was uncommon and occurred most often in the first trimester as prophylaxis following trauma. No increase in adverse outcomes was identified in infants born to women receiving Tdap compared with infants of controls.

Keywords: ACIP; Advisory Committee on Immunization Practices; EDW; Enterprise Data Warehouse; ICD-9-CM; International Classification of Diseases, Ninth Revision, Clinical Modification; Tdap; Tetanus, diphtheria, acellular pertussis.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Reason for Health Care Visit and Trimester at Time of Tdap Vaccine Administration
See this image and copyright information in PMC

References

    1. Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Tdap) in pregnant women and persons who have or anticipate having close contact with an infant aged <12 months --- Advisory Committee on Immunization Practices (ACIP), 2011. MMWR Morbidity and mortality weekly report. 2011;60:1424–6. - PubMed
    1. Murphy TV, Slade BA, Broder KR, et al. Prevention of pertussis, tetanus, and diphtheria among pregnant and postpartum women and their infants recommendations of the Advisory Committee on Immunization Practices (ACIP) MMWR Recommendations and reports : Morbidity and mortality weekly report Recommendations and reports / Centers for Disease Control. 2008;57:1–51. - PubMed
    1. Tanaka M, Vitek CR, Pascual FB, Bisgard KM, Tate JE, Murphy TV. Trends in pertussis among infants in the United States, 1980-1999. JAMA : the journal of the American Medical Association. 2003;290:2968–75. - PubMed
    1. Haberling DL, Holman RC, Paddock CD, Murphy TV. Infant and maternal risk factors for pertussis-related infant mortality in the United States, 1999 to 2004. The Pediatric infectious disease journal. 2009;28:194–8. - PubMed
    1. Halperin SA. Pertussis--a disease and vaccine for all ages. The New England journal of medicine. 2005;353:1615–7. - PubMed

Publication types

Substances